Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme (Q46902584)

26 December 2017

title

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme (English)

1 reference

26 December 2017

1 reference

11

Angelo Tremblay

1 reference

26 December 2017

Marie-Josée Poulin

1

1 reference

26 December 2017

Jean-Philippe Chaput

2

1 reference

26 December 2017

Véronique Simard

3

1 reference

26 December 2017

Pierre Vincent

4

1 reference

26 December 2017

Joëlle Bernier

5

1 reference

26 December 2017

Yvan Gauthier

6

1 reference

26 December 2017

Guy Lanctôt

7

1 reference

26 December 2017

Jacynthe Saindon

8

1 reference

26 December 2017

Annick Vincent

9

1 reference

26 December 2017

Solange Gagnon

10

1 reference

26 December 2017

publication date

1 December 2007

1 reference

26 December 2017

Australian and New Zealand Journal of Psychiatry

published in

1 reference

26 December 2017

volume

41

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

980-989

1 reference

26 December 2017

Measurement of appetite disturbances in psychiatric disorders

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Association of olanzapine-induced weight gain with an increase in body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

The impact of weight gain on quality of life among persons with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Obesity as a risk factor for antipsychotic noncompliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Bodyweight gain with atypical antipsychotics. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

A review of the effect of atypical antipsychotics on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Weight gain profiles of new anti-psychotics: public health consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Weight loss with psychiatric residents in a behavioral self control program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

A study of weight reducing diets in psychiatric in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

A program for treating olanzapine-related weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Integrating physical activity into mental health services for persons with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Schizophrenia and weight management: a systematic review of interventions to control weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Weight loss in overweight patients maintained on atypical antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Interventions for Weight Gain in Adults Treated With Novel Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Cardiovascular risk factors for people with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Obesity: a disease or a biological adaptation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

Exercise as an adjunct treatment for schizophrenia: A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701689428

10.1080/00048670701689428

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017